Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT00724256
Eligibility Criteria:
Inclusion Criteria:
* Children aged 1 month to 5 years, with a first episode of pyelonephritis.
Exclusion Criteria:
* Children less than 1 month, or older than 5 years.
* Relapse of pyelonephritis.
* Sepsis and/or vomiting, or other conditions where it's impossible to administer an oral therapy.
* Allergy to ceftibuten.
* Previous antibiotic therapy for the same infection.
* Long term antibiotic prophylaxis with an antibiotic of the same class, if laboratory antibiotic resistance is shown.
* Children with uncontrolled other disease.
* Complicated pyelonephritis (abscess).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
5 Years
Study:
NCT00724256
Study Brief:
Protocol Section:
NCT00724256